The collaboration will aim to develop and implement graphene and carbon-based materials for use in complex biosensing which can target applications in human health. Research will explore graphene-based materials for complex biosensing to generate patents with commercial applications and will combine AXE's graphite and graphene materials with the research and development capability of the university.
The key focus for AXE's collaboration with Adelaide University will be to develop generic biosensors that can address the largest market segments for biosensors and medical testing; specifically, detection of cholesterol, blood glucose, blood gases, pregnancy, infectious diseases and drugs.
Source: